For a captioned version or to access the transcript, please visit: https://www.pharmaron.com/knowledge-center/dmpk-insights-12-bbb-transporters/
In this podcast, Elena and Mikko will discuss the current state-of-the-art around transporter sub-types and their expression within the blood-brain barrier (BBB) and opportunities for utilizing these transporters for brain drug delivery.
We will address the following questions:
Our Speakers:
Dr. Elena Puris – Academic Research Fellow and Associate Professor in Neuropharmacology at the University of Eastern Finland
Dr. Elena Puris is an associate professor of neuropharmacology and senior researcher at the University of Eastern Finland. During her PhD at the University of Eastern Finland and postdoctoral research at Heidelberg University, Elena developed a strong interest in blood-brain barrier transporters and their roles in drug delivery and disease pathogenesis. She has a multidisciplinary background in drug development and over 15 years of experience in academia and the pharmaceutical industry. Elena’s main research focus is membrane transporters and their impact on drug delivery and biochemical processes in health and pathological conditions.
Dr. Mikko Gynther – Senior Researcher and Associate Professor in Biopharmacy at the University of Eastern Finland
Dr. Mikko Gynther is an associate professor of biopharmacy and senior researcher at the School of Pharmacy, University of Eastern Finland. He obtained his PhD in pharmacy at the University of Eastern Finland on utilizing glucose and amino acid transporters for the CNS delivery of prodrugs. He has extensive experience spanning 20 years in transporter-mediated drug delivery and pharmacokinetics research. Mikko’s current research is focused on transporter-mediated drug delivery into the brain and cancer cells and utilizing proteomics to investigate disease-induced changes in drug transporters and enzymes.
Stay tuned for more podcasts in our Pharmaron DMPK Insights Series!